Literature DB >> 34413940

Novel Histone Acetyltransferase (HAT) Inhibitors for Treating Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34413940      PMCID： PMC8365625          DOI： 10.1021/acsmedchemlett.1c00337

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  4 in total

Review 1.  Histone acetyl transferases and their epigenetic impact on bone remodeling.

Authors:  K Gomathi; N Akshaya; N Srinaath; M Rohini; N Selvamurugan
Journal:  Int J Biol Macromol       Date:  2020-12-26       Impact factor: 6.953

Review 2.  Cognitive epigenetic priming: leveraging histone acetylation for memory amelioration.

Authors:  Allison M Burns; Johannes Gräff
Journal:  Curr Opin Neurobiol       Date:  2020-10-26       Impact factor: 6.627

Review 3.  Targeting histone acetylation/deacetylation in parasites: an update (2017-2020).

Authors:  Rossella Fioravanti; Nicola Mautone; Annarita Rovere; Dante Rotili; Antonello Mai
Journal:  Curr Opin Chem Biol       Date:  2020-06-29       Impact factor: 8.822

Review 4.  Current development of CBP/p300 inhibitors in the last decade.

Authors:  Zhang-Xu He; Bing-Fei Wei; Xin Zhang; Yun-Peng Gong; Li-Ying Ma; Wen Zhao
Journal:  Eur J Med Chem       Date:  2020-10-01       Impact factor: 6.514
  4 in total
  2 in total

1.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-09

2.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Med Chem Lett       Date:  2022-10-13       Impact factor: 4.632
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.